CD4 and neoplasm: Additionally, cucurbitacin B can inhibit the JAK2/STAT3 signaling pathway, reduce the migration and invasion ability of M2-like TAM polarization-induced colon cancer cells, enhance the anti-tumor response, and increase the expression of CD4 and CD8 in the tumor microenvironment.